Guillain-Barré syndrome (GBS) is an immune-mediated demyelinating polyneuropathy characterized by progressive, ascending, and symmetrical paralysis. It is known to be triggered by an antecedent infection or vaccination. Recently, GBS development following coronavirus disease 2019 (COVID-19) vaccination has been reported. Cranial neuropathies in typical GBS patients usually involve the facial and the lower cranial nerves (from IX to XII). We report a rare case of multiple cranial neuropathies involving trigeminal, abducens, and facial nerves in a patient who developed GBS following COVID-19 vaccination on the basis of obvious MRI features
BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primarily affects the respira...
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the infectious agent res...
Guillain–Barré syndrome (GBS) is a potentially fatal, immune-mediated disease of the peripheral nerv...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent for Coronavirus di...
Guillain-Barré syndrome (GBS) is an acute inflammatory polyradiculoneuropathy. In two-thirds of pati...
Guillain-Barré-Syndrome (GBS) is one of the reported neurological manifestations linked to a severe ...
Guillain-Barré syndrome (GBS) is an immune-mediated demyelinating disorder which attacks the periphe...
Background and Purpose: Recent population-based studies from the US and UK have identified an increa...
Guillain-Barré Syndrome (GBS) is a complex autoimmune disorder where a person’s own immune system da...
With the outbreak of coronavirus disease 2019 (COVID-19), the whole world was impacted by a pandemic...
INTRODUCTION: The novel coronavirus (COVID-19) is a global pandemic. Although the main clinical man...
8noGuillain-Barré syndrome (GBS) is an acute polyradiculoneuropathy associated with dysimmune proces...
Guillain-Barre syndrome (GBS) is an acute immune-mediated neuropathy, possibly triggered by a recent...
Coronavirus Disease has become a global pandemic after its emergence at the end of 2019 as a cluster...
9noWe report a case series of five patients affected by SARS-CoV-2 who developed neurological sympto...
BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primarily affects the respira...
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the infectious agent res...
Guillain–Barré syndrome (GBS) is a potentially fatal, immune-mediated disease of the peripheral nerv...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent for Coronavirus di...
Guillain-Barré syndrome (GBS) is an acute inflammatory polyradiculoneuropathy. In two-thirds of pati...
Guillain-Barré-Syndrome (GBS) is one of the reported neurological manifestations linked to a severe ...
Guillain-Barré syndrome (GBS) is an immune-mediated demyelinating disorder which attacks the periphe...
Background and Purpose: Recent population-based studies from the US and UK have identified an increa...
Guillain-Barré Syndrome (GBS) is a complex autoimmune disorder where a person’s own immune system da...
With the outbreak of coronavirus disease 2019 (COVID-19), the whole world was impacted by a pandemic...
INTRODUCTION: The novel coronavirus (COVID-19) is a global pandemic. Although the main clinical man...
8noGuillain-Barré syndrome (GBS) is an acute polyradiculoneuropathy associated with dysimmune proces...
Guillain-Barre syndrome (GBS) is an acute immune-mediated neuropathy, possibly triggered by a recent...
Coronavirus Disease has become a global pandemic after its emergence at the end of 2019 as a cluster...
9noWe report a case series of five patients affected by SARS-CoV-2 who developed neurological sympto...
BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primarily affects the respira...
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the infectious agent res...
Guillain–Barré syndrome (GBS) is a potentially fatal, immune-mediated disease of the peripheral nerv...